about
Adjuvant immunotherapy of dendritic cells and cytokine-induced killer cells is safe and enhances chemotherapy efficacy for multiple myeloma in China: a meta-analysis of clinical trials.Lenalidomide and Programmed Death-1 Blockade Synergistically Enhances the Effects of Dendritic Cell Vaccination in a Model of Murine Myeloma.Synergistic Antimyeloma Activity of Dendritic Cells and Pomalidomide in a Murine Myeloma Model
P2860
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Immunotherapy for the treatment of multiple myeloma.
@en
Immunotherapy for the treatment of multiple myeloma.
@nl
type
label
Immunotherapy for the treatment of multiple myeloma.
@en
Immunotherapy for the treatment of multiple myeloma.
@nl
prefLabel
Immunotherapy for the treatment of multiple myeloma.
@en
Immunotherapy for the treatment of multiple myeloma.
@nl
P2093
P1476
Immunotherapy for the treatment of multiple myeloma
@en
P2093
Hyeoung-Joon Kim
Hyun-Ju Lee
Je-Jung Lee
Manh-Cuong Vo
P356
10.1016/J.CRITREVONC.2017.01.011
P577
2017-01-27T00:00:00Z